To investigate whether DNA methylation is involved in the decreased expression of GADD45g in MPNs, we treated MPN cell lines HEL and SET-2, and primary BMMNCs from MPN patients with DNA demethylating agent Decitabine. Here, GADD45G is linked to myeloproliferative neoplasm.